nm.2018-Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
本文档由 Science 分享于2018-09-02 16:01
暂无简介
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~